Business Sundial sees Q4 revenue jump 63% to $22.7M Sundials's EBITDA increased to $18.4 million during the fourth quarter, up 75 per cent from the previous quarter Ryan GarnerApril 28, 2022
Business Tilray Q3 revenue dips 2% to US$151.9M The company says it has a 20% market share in Germany with its whole flower, extracts and Dronabinol products Natalia Buendia CalvilloApril 7, 2022
Business Trulieve posts record 2021 revenue of US$938.4M The firm is forecasting 2022 revenue of at least US$1.3B Nick LabaMarch 30, 2022
Business Planet 13 ups annual revenue 70% to US$119.5M The company says it's working hard to operationalize assets acquired over the past year Nick LabaMarch 29, 2022
Business 2021 sales up 27% to US$15.4M for Clever Leaves And 2022 is looking like a bright year for international medical cannabis markets Nick LabaMarch 24, 2022
Business Charlotte’s Web reports steep losses in 2021 The firm is still waiting for long-promised CBD product guidelines in the US Nick LabaMarch 24, 2022
Business Cresco Labs boosts annual sales 73% to US$821.7M But the firm acknowledges a market slowdown in Q4 it was 'not immune to' Nick LabaMarch 23, 2022
Business Nova Cannabis boosts annual sales 112% to $134.4M Its majority shareholder Alcanna is set to be bought by Sundial for $346M at the end of March Nick LabaMarch 21, 2022
Business Hexo reports $616M write-down in Q1 The firm says the charges give it a 'clean slate' for future growth Nick LabaMarch 18, 2022
Business Annual sales up 131% to US$357.6M for Ayr Wellness The company says it expects revenue from capital expenditure projects to ramp up this year Nick LabaMarch 17, 2022